Analysis | Metabolite Name | Measured Value | Units | Cell Type | Stimulation |
---|---|---|---|---|---|
Reversed phase POSITIVE ION MODE | N-ALPHA-ACETYL-L-LYSINE (CAS# 1946-82-3); (M+H)+ | 1575 | Peak area | PAK | Untreated |
Reversed phase POSITIVE ION MODE | N-ALPHA-ACETYL-L-LYSINE (CAS# 1946-82-3); (M+H)+ | 27813 | Peak area | BS4 | TNF-alpha+IL-17A |
Reversed phase POSITIVE ION MODE | N-ALPHA-ACETYL-L-LYSINE (CAS# 1946-82-3); (M+H)+ | 32053 | Peak area | PAK | TNF-alpha+IL-17A |
Reversed phase POSITIVE ION MODE | N-ALPHA-ACETYL-L-LYSINE (CAS# 1946-82-3); (M+H)+ | 32445 | Peak area | BS4 | Untreated |
Reversed phase POSITIVE ION MODE | N-ALPHA-ACETYL-L-LYSINE (CAS# 1946-82-3); (M+H)+ | Peak area | BS4 | IFN-G | |
Reversed phase POSITIVE ION MODE | N-ALPHA-ACETYL-L-LYSINE (CAS# 1946-82-3); (M+H)+ | Peak area | BS4 | IL-17A | |
Reversed phase POSITIVE ION MODE | N-ALPHA-ACETYL-L-LYSINE (CAS# 1946-82-3); (M+H)+ | Peak area | BS4 | TNF-alpha | |
Reversed phase POSITIVE ION MODE | N-ALPHA-ACETYL-L-LYSINE (CAS# 1946-82-3); (M+H)+ | Peak area | HAHA | IFN-G | |
Reversed phase POSITIVE ION MODE | N-ALPHA-ACETYL-L-LYSINE (CAS# 1946-82-3); (M+H)+ | Peak area | HAHA | IL-17A | |
Reversed phase POSITIVE ION MODE | N-ALPHA-ACETYL-L-LYSINE (CAS# 1946-82-3); (M+H)+ | Peak area | HAHA | TNF-alpha | |
Reversed phase POSITIVE ION MODE | N-ALPHA-ACETYL-L-LYSINE (CAS# 1946-82-3); (M+H)+ | Peak area | HAHA | TNF-alpha+IL-17A | |
Reversed phase POSITIVE ION MODE | N-ALPHA-ACETYL-L-LYSINE (CAS# 1946-82-3); (M+H)+ | Peak area | HAHA | Untreated | |
Reversed phase POSITIVE ION MODE | N-ALPHA-ACETYL-L-LYSINE (CAS# 1946-82-3); (M+H)+ | Peak area | PAK | IFN-G | |
Reversed phase POSITIVE ION MODE | N-ALPHA-ACETYL-L-LYSINE (CAS# 1946-82-3); (M+H)+ | Peak area | PAK | IL-17A | |
Reversed phase POSITIVE ION MODE | N-ALPHA-ACETYL-L-LYSINE (CAS# 1946-82-3); (M+H)+ | Peak area | PAK | TNF-alpha |